Your browser doesn't support javascript.
loading
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.
Kingston, Belinda; Bailleux, Caroline; Delaloge, Suzette; Schiavon, Gaia; Scott, Veronique; Lacroix-Triki, Magali; Carr, T Hedley; Kozarewa, Iwanka; Gevensleben, Heidrun; Kemp, Zoe; Pearson, Alex; Turner, Nicholas; André, Fabrice.
Afiliação
  • Kingston B; Institute of Cancer Research, London, United Kingdom.
  • Bailleux C; Institut Gustave Roussy, Villejuif, France.
  • Delaloge S; Institut Gustave Roussy, Villejuif, France.
  • Schiavon G; Institut Gustave Roussy, Villejuif, France.
  • Scott V; AstraZeneca, IMED Oncology, Cambridge, United Kingdom.
  • Lacroix-Triki M; Institut Gustave Roussy, Villejuif, France.
  • Carr TH; Institut Gustave Roussy, Villejuif, France.
  • Kozarewa I; Institut Gustave Roussy, Villejuif, France.
  • Gevensleben H; AstraZeneca, IMED Oncology, Cambridge, United Kingdom.
  • Kemp Z; AstraZeneca, IMED Oncology, Cambridge, United Kingdom.
  • Pearson A; Bonn University Hospital, Bonn, Germany.
  • Turner N; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • André F; Institute of Cancer Research, London, United Kingdom.
JCO Precis Oncol ; 32019.
Article em En | MEDLINE | ID: mdl-32923864
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido